Richard Slansky
2017 - OncoSec Medical
In 2017, Richard Slansky earned a total compensation of $520.5K as Chief Financial Officer at OncoSec Medical, a 41% decrease compared to previous year.
Compensation breakdown
| Option Awards | $86,869 |
|---|---|
| Salary | $299,616 |
| Stock Awards | $134,000 |
| Total | $520,485 |
Slansky received $299.6K in salary, accounting for 58% of the total pay in 2017.
Slansky also received $86.9K in option awards and $134K in stock awards.
Rankings
In 2017, Richard Slansky's compensation ranked 11,700th out of 14,666 executives tracked by ExecPay. In other words, Slansky earned more than 20.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,700 out of 14,666 | 20th |
Division Manufacturing | 4,599 out of 5,772 | 20th |
Major group Chemicals And Allied Products | 1,682 out of 2,075 | 19th |
Industry group Drugs | 1,392 out of 1,731 | 20th |
Industry Pharmaceutical Preparations | 1,088 out of 1,333 | 18th |
Source: SEC filing on November 28, 2017.
Slansky's colleagues
We found two more compensation records of executives who worked with Richard Slansky at OncoSec Medical in 2017.